Co-Diagnostics, Inc. - Common Stock (CODX)
0.2625
-0.0044 (-1.65%)
NASDAQ · Last Trade: Jun 28th, 5:19 PM EDT
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · June 26, 2025
Via Benzinga · June 26, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 20, 2025
Via Benzinga · June 20, 2025
Via Benzinga · June 16, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · May 26, 2025
Via Benzinga · April 28, 2025
Via Benzinga · April 1, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · March 25, 2025

Co-Diagnostics plans to submit an enhanced COVID-19 test for FDA clearance, addressing stability concerns and integrating platform advancements.
Via Benzinga · February 24, 2025

Via Benzinga · January 14, 2025

CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024

Via Benzinga · June 10, 2024

Via Benzinga · June 6, 2024

CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024